Price hikes = more cereal byproducts in animal feed. What about mycotoxin risk?

animal feed

By Marisabel Caballero, Global Technical Manager Poultry, EW Nutrition

Most grains used in feed are susceptible to mycotoxin contamination, causing severe economic losses all along feed value chains. As skyrocketing raw material prices force producers to include a higher proportion of economical cereal byproducts in the feed, the risks of mycotoxin contamination likely increase. In this article, we review why mycotoxins cause the damage they do – and how effective toxin-mitigating solutions prevent this damage.

Mycotoxin contamination of cereal byproducts requires solutions

Cereal byproducts may become more important feed ingredients as grain prices increase. But also from a sustainability point of view and considering population growth, using cereal byproducts in animal feed makes  a lot of sense. Dried distiller’s grains with solubles (DDGS) are a good example of how byproducts from food processing industries can become high-quality animal feed.

Figure 1: Byproducts are a crucial protein source (data from FEFAC Feed & Food 2021 report)

Still, research on what happens to mycotoxins during food processing shows that mycotoxins are concentrated into fractions that are commonly used as animal feed (cf. Pinotti et al., 2016 + link to article IH+MC ). To safeguard animal health and performance when feeding lower-quality cereals, it is essential to monitor mycotoxin risks through regular testing and to use toxin-mitigating solutions.

Problematic effects of mycotoxins on the intestinal epithelium

Most mycotoxins are absorbed in the proximal part of the gastrointestinal tract. This absorption can be high, as in the case of aflatoxins (ca. 90%), but also very limited, as in the case of fumonisins (< 1%); moreover, it depends on the species. Importantly, a significant portion of unabsorbed toxins remains within the lumen of the gastrointestinal tract.

Importantly, studies based on realistic mycotoxin challenges (e.g., Burel et al., 2013) show that the mycotoxin levels necessary to trigger damaging processes are lower than the levels reported as safe by EFSA, the Food Safety Agency of the European Union. The ultimate consequences range from diminished nutrient absorption to inflammatory responses and pathogenic disorders in the animal (Figure 2).

Figure 2: Mycotoxins’ impact on the GIT and consequences for monogastric animals

  1.  Alteration of the intestinal barrier‘s morphology and functionality

    Several studies indicate that mycotoxins such as aflatoxin B1, DON, fumonisin B1, ochratoxin A, and T2, can increase the permeability of the intestinal epithelium of poultry and swine (e.g. Pinton & Oswald, 2014). This is mostly a consequence of the inhibition of protein synthesis.

    As a result, there is an increase in the passage of antigens into the bloodstream (e.g., bacteria, viruses, and toxins). This increases the animal’s susceptibility to infectious enteric diseases. Moreover, the damage that mycotoxins cause to the intestinal barrier entails that they are also being absorbed at a higher rate.

  2. Impaired immune function in the intestine

    The intestine is a very active immune site, where several immuno-regulatory mechanisms simultaneously defend the body from harmful agents. Immune cells are affected by mycotoxins through the initiation of apoptosis, the inhibition or stimulation of cytokines, and the induction of oxidative stress.

    For poultry production, one of the most severe enteric problems of bacterial origin is necrotic enteritis, which is caused by Clostridium perfringens toxins. Any agent capable of disrupting the gastrointestinal epithelium – e.g. mycotoxins such as DON, T2, and ochratoxin – promotes the development of necrotic enteritis.

  3. Alteration of the intestinal microflora

    Recent studies on the effect of various mycotoxins on the intestinal microbiota show that DON and other trichothecenes favor the colonization of coliform bacteria in pigs. DON and ochratoxin A also induce a greater invasion of Salmonella and their translocation to the bloodstream and vital organs in birds and pigs – even at non-cytotoxic concentrations.

    It is known that fumonisin B1 may induce changes in the balance of sphingolipids at the cellular level, including for gastrointestinal cells. This facilitates the adhesion of pathogenic bacteria, increases in their populations, and prolongs infections, as has been shown for the case of E. coli. The colonization of the intestine of food-producing animals by pathogenic strains of E. coli and Salmonella also poses a risk for human health.

  4. Interaction with bacterial toxins

    When mycotoxins induce changes in the intestinal microbiota, this can lead to an increase in the endotoxin concentration in the intestinal lumen. Endotoxins promote the release of several cytokines that induce an enhanced immune response, causing inflammation, thus reducing feed consumption and animal performance, damage to vital organs, sepsis, and death of the animals in some cases.

    The synergy between mycotoxins and endotoxins can result in an overstimulation of the immune system. The interaction between endotoxins and estrogenic agents such as zearalenone, for example, generates chronic inflammation and autoimmune disorders because immune cells have estrogen receptors, which are stimulated by the mycotoxin.

Increased mycotoxin risks through byproducts? Invest in mitigation solutions

To prevent the detrimental consequences of mycotoxins on animal health and performance, proactive solutions are needed that support the intestinal epithelium’s digestive and immune functionality and help maintain a balanced microbiome in the GIT. As the current market conditions will likely engender a long-term shift towards the inclusion of more cereal byproducts in animal diets, this becomes even more important.

Trial data shows that EW Nutrition’s toxin-mitigating solution SOLIS MAX provides effective protection against feedborne mycotoxins. The synergistic combination of ingredients in SOLIS MAX mycotoxins from damaging the animals’ gastrointestinal tract and entering the blood stream:

In-vitro study shows SOLIS MAX’ strong mitigation effects against wide range of mycotoxins

Animal feed is often contaminated with two or more mycotoxins, making it important for an anti-mycotoxin agent to be effective against a wide range of different mycotoxins. A dose response evaluation of SOLIS MAX was conducted a at an independent laboratory in Spain, for inclusion levels of 0.10%, 0.15%, and 0.20% (equivalent to 1 kg, 1.5 kb, and 2 kg per ton of feed). A phosphate buffer solution at pH 7 was prepared to simulate intestinal conditions in which a portion of the mycotoxins may be released from the binder (desorption).

Each mycotoxin was tested separately by adding a challenge to buffer solutions, incubating for one hour at 41°C, to establish the base line (see table). At the same time a solution with the toxin challenge and SOLIS MAX was prepared, incubated, and analyzed for the residual mycotoxin. All analyses were carried out by high performance liquid chromatography (HPLC) with standard detectors.

Figure 3: SOLIS MAX adsorption capacity against different mycotoxins (%)

The results demonstrate that SOLIS MAX is a very effective solution against the most common mycotoxins found in raw materials and animal feed, showing clear dose-response effects.

Mycotoxin risk management for better animal feed

A healthy gastrointestinal tract is crucial to animals’ overall health: it ensures that nutrients are optimally absorbed, it provides effective protection against pathogens through its immune function, and it is key to maintaining a well-balanced microflora. Even at levels considered safe by the European Union, mycotoxins can compromise different intestinal functions, resulting in lower productivity and susceptibility to disease.

The globalized feed trade, which spreads mycotoxins beyond their geographical origin, climate change and raw material market pressures only escalates the problem. On top of rigorous testing, producers should mitigate unavoidable mycotoxin exposures through the use of solutions such as SOLIS MAX – for stronger animal health, welfare, and productivity.

References

Antonissen, Gunther, An Martel, Frank Pasmans, Richard Ducatelle, Elin Verbrugghe, Virginie Vandenbroucke, Shaoji Li, Freddy Haesebrouck, Filip Van Immerseel, and Siska Croubels. “The Impact of Fusarium Mycotoxins on Human and Animal Host Susceptibility to Infectious Diseases.” Toxins 6, no. 2 (January 28, 2014): 430–52. https://doi.org/10.3390/toxins6020430.

Burel, Christine, Mael Tanguy, Philippe Guerre, Eric Boilletot, Roland Cariolet, Marilyne Queguiner, Gilbert Postollec, et al. “Effect of Low Dose of Fumonisins on Pig Health: Immune Status, Intestinal Microbiota and Sensitivity to Salmonella.” Toxins 5, no. 4 (April 23, 2013): 841–64. https://doi.org/10.3390/toxins5040841.

Burton, Emily J., Dawn V. Scholey, and Peter E. Williams. “Use of Cereal Crops for Food and Fuel – Characterization of a Novel Bioethanol Coproduct for Use in Meat Poultry Diets.” Food and Energy Security 2, no. 3 (September 19, 2013): 197–206. https://doi.org/10.1002/fes3.30.

Ghareeb, Khaled, Wageha A. Awad, Josef Böhm, and Qendrim Zebeli. “Impacts of the Feed Contaminant Deoxynivalenol on the Intestine of Monogastric Animals: Poultry and Swine.” Journal of Applied Toxicology 35, no. 4 (October 28, 2014): 327–37. https://doi.org/10.1002/jat.3083.

Mani, V., T. E. Weber, L. H. Baumgard, and N. K. Gabler. “Growth and Development Symposium: Endotoxin, Inflammation, and Intestinal Function in livestock1,2.” Journal of Animal Science 90, no. 5 (May 1, 2012): 1452–65. https://doi.org/10.2527/jas.2011-4627.

Obremski, K. “The Effect of in Vivo Exposure to Zearalenone on Cytokine Secretion by Th1 and Th2 Lymphocytes in Porcine Peyer’s Patches after in Vitro Stimulation with LPS.” Polish Journal of Veterinary Sciences 17, no. 4 (2014): 625–32. https://doi.org/10.2478/pjvs-2014-0093.

Oswald, I. P., C. Desautels, J. Laffitte, S. Fournout, S. Y. Peres, M. Odin, P. Le Bars, J. Le Bars, and J. M. Fairbrother. “Mycotoxin Fumonisin B1 Increases Intestinal Colonization by Pathogenic Escherichia Coli in Pigs.” Applied and Environmental Microbiology 69, no. 10 (2003): 5870–74. https://doi.org/10.1128/aem.69.10.5870-5874.2003.

Pinotti, Luciano, Matteo Ottoboni, Carlotta Giromini, Vittorio Dell’Orto, and Federica Cheli. “Mycotoxin Contamination in the EU Feed Supply Chain: A Focus on Cereal Byproducts.” Toxins 8, no. 2 (February 15, 2016): 45. https://doi.org/10.3390/toxins8020045.

Pinton, Philippe, and Isabelle Oswald. “Effect of Deoxynivalenol and Other Type B Trichothecenes on the Intestine: A Review.” Toxins 6, no. 5 (May 21, 2014): 1615–43. https://doi.org/10.3390/toxins6051615.




Piglet performance with fewer antimicrobials is possible

veterinarianholdingdryfoodingranulesinhandsandoffering

By Technical Team, EW Nutrition

A variety of stressors simultaneously occur at weaning, making this probably the most challenging period in pig production. During weaning, we commonly see altered gut development and gut microbiome, which increases piglets’ vulnerability to diseases. The most classic clinical symptom resulting from these stressors is the occurrence of post-weaning diarrhea. It is a sign that something went wrong, and piglet development and overall performance may be compromised (Guevarra et al. 2019).

Besides weaning, an unavoidable practice in pig production, the swine industry has been facing other changes. Among them, the increased pressure to reduce the use of antimicrobials stands out. Antimicrobials are often associated with improved piglet performance and health. Their usage has been reduced worldwide, however, due to the threat of antimicrobial resistance that affects not just animal health but also human health (Cardinal et al., 2019).

Reduce antimicrobials and post-weaning diarrhea: can piglet nutrition achieve both?

With these drastic changes for the piglets and the global swine industry, producers must find solutions to keep their farms profitable — especially from a nutritional perspective. Our last article presented two feed additives that can be part of an antibiotic-free concept for post-weaning piglets. This article will highlight a few essential nutritional strategies that swine producers and nutritionists must consider when formulating post-weaning feed without or with reduced amounts of antimicrobials.

Pigs

What makes weaning so stressful for piglets?

Producers, nutritionists, and veterinarians all agree that weaning is a tough time for piglets (Yu et al., 2019) and, therefore, a challenge to all those involved in the pig production chain. Although there is a global trend towards increasing weaning age, generally speaking, animals are still immature when going through the weaning process. They face several physiological, nutritional, and environmental changes (figure 1).

Healthy Piglets
Figure 1. Factors associated with weaning can compromise piglet well-being and performance

Most of these changes become “stressors” that trigger a cascade of reactions affecting the balance and morphology of the intestinal microbiome (figure 2). The outcome is a decrease in the piglets’ well-being and, in most cases, performance. We need to clearly understand how these stressors affect pigs to develop effective strategies against post-weaning growth impairments, especially when no antimicrobials are allowed.

 

Schematic diagram
Figure 2. Schematic diagram illustrating the effects of stress in weaned piglets (adapted from Jayaraman and Nyachoti, 2017)

Weaning support starts before weaning

The use of creep feed has been evaluated and even criticized for many years. Some operations are still reluctant to use such a feed due to its high cost and amount of labor on the farm, with manually providing feed and cleaning feeding trays. In addition, some questions have been raised regarding the ideal composition of the creep feed – how much complexity should we add to this special diet?

Therefore, the benefits of creep feed are under re-evaluation, not only considering piglet physiology per se, but also feed characteristics and different feeding programs. Recent studies have questioned highly complex creep feed formulations. Creep feed is being called “transition feed” (Molist, 2021) – i.e., that meal which is complementary to sows’ milk and not a replicate of it, helping piglets during the period of changing its main source of nutrients. We must, therefore, look at it as a way of making piglets familiar with solid feed, as highlighted by Mike Tokach during the 2020 KSU Swine Day. Dr. Tokach also mentioned that the presence of feeders in the lactation pen could stimulate the exploratory behaviors of the piglets. Combined, these practices can lead to a higher feed intake and performance during the nursery phase.

Towards a pragmatic stance on creep feed

Heo et al. (2018) evaluated three different creep feed types: a highly digestible creep feed, weaning feed as creep feed, and sow feed as creep feed until weaning. Piglets receiving the highly digestible creep had higher feed intake during the second to the last week pre-weaning (14 to 21 days of age) and higher ADG during the last week pre-weaning (21 to 28 days of age). This resulted in a trend for higher weaning weight. However, these benefits did not persist after weaning when all piglets received the weaning feed.

Guevarra et al. (2019) also suggested that the abrupt transition in piglet nutrition to a more complex nutrient source can influence shifts in the gut microbiota, impacting the absorptive capacity of the small intestine. Yang et al. (2016) evaluated 40 piglets from eight litters during the first week after weaning. They found that the change in diet during weaning reduced the proliferation of intestinal epithelial cells. This indicates that this period affects cellular macromolecule organization and localization, in addition to energy and protein metabolism. These results suggest that “similarity” in feed pre- and post-weaning may contribute more to the continuity of nutrient intake post-weaning than a highly complex-nutrient dense creep feed.

Nutritional strategies without antibiotics: focus on pig physiology

As mentioned, it is crucial to avoid a drastic drop in feed/nutrient intake after weaning compared to pre-weaning levels. In a classic study, Pluske et al. (1996) showed the importance of high intake levels on villus weight (used as a reference for gut health, cf. graph 1). Although not desirable, the reduction should be considered “normal” behavior.

Imagine these recently weaned piglets, facing all these stressors, having to figure out within this new group of peers when it is time to eat, where to find food, why water and food now come from two distinct sources… Therefore, management, feeding, water quality, and other aspects play important roles in post-weaning feed intake (figure 3).

Average villus height
Graph 1. Villus height following different levels of feed intake (M = maintenance) post-weaning (a.b.c bars with unlike superscript letters are different at P<0.05). (From Pluske et al., 1996.)

From a nutritional perspective, piglets at weaning experience a transition from milk (a high-fat, low-carbohydrate liquid) to a plant-based diet (a solid, low-fat, and high-carbohydrate diet) (Guevarra et al., 2019). Even when previously introduced to solid feed, it is still difficult for their enzymatic system to cope with grains and beans.

One of the consequences of the lower digestibility capacity is an increase of undigested nutrients. Harmful bacteria thrive and cause diarrhea, reducing even further an already compromised feed intake. This cycle must be broken with the support of formulations based on piglet physiology.

Post-weaning feed must support digestion and nutrient absorption, including the largest possible share possible of high-quality, digestible ingredients, with low anti-nutritional factors. High-performing feed also integrates functional amino acids, functional carbohydrates, and additives to support the intestinal mucosa and gut microbiome.

Supporting piglets with effective solutions

Figure 3. Supporting piglets with effective solutions

Crude protein – more of the same?

Levels of crude protein in piglet feed have been in the spotlight for quite some time. The topic can be very controversial where the exact percentage of crude protein in the final feed is concerned. Some nutritionists pragmatically recommend maximal levels of 20% in the weaner feed. Others go a bit lower, with some formulations reaching 17 to 18% total crude protein. Levels above 20% will incur high costs and may accentuate the growth of pathogenic bacteria due to a higher amount of undigested protein in the distal part of the small intestine (figure 4).

crude protein levels in piglet feed
Figure 4. The dynamics of crude protein levels in piglet feed

What is not open for discussion, however, is the quality of the protein used, in terms of:

  • digestibility,
  • the total amount of anti-nutritional factors, and
  • the correct supply of essential and non-essential amino acids (particularly lysine, methionine, threonine, tryptophane, isoleucine and valine).

The critical role of digestibility

High-digestibility ingredients for piglets need to deliver minimum 85% digestibility. In most cases, to reach high biological values (correlating to high digestibility), these ingredients typically undergo different processing steps, including heat, physical, and chemical treatments. Animal by-products (such as hydrolyzed mucosa, fish meal, spray-dried plasma) and processed vegetable sources (soy protein concentrate, extruded grains, potato protein) can be used in high amounts during this phase. They will notably reduce the total amount of undigested protein reaching the distal part of the intestine, with 2 main benefits:

  • Less substrate for pathogenic bacteria proliferation (and therefore lower incidence of diarrhea)
  • Lower nitrogen excretion to the environment

 

Animal Feeds

It is common knowledge that certain storage proteins from soybean meal (for instance, glycinin and B-conglycinin) can cause damage to piglets’ intestinal morphology and trigger the activation of the immune system. However, it is normal practice to introduce this ingredient to piglets around weaning so that the animals can develop a certain level of tolerance to such compounds (Tokach et al., 2003). In Europe, where most diets are wheat-barley based, soybean meal is included in levels varying from 3 to 9% in the first 2 diets, with gradual increases during the nursery phase.

Amino acids and protein: manage the balance

When the supply and balance between essential and non-essential amino acids is concerned, reducing total crude protein brings indeed complexity to the formulations. The concept of ideal amino acid should be expanded, ideally, to all 9 essential amino acids (lysine, methionine, tryptophan, threonine, valine, isoleucine, leucine, histidine, and phenylalanine). In most cases, formulations go up to the 5th or 6th limiting amino acid. Lawor et al. (2020) suggest 2 practical approaches to avoid deficiencies when formulating low-protein piglet feed:

  • Maintain a maximum total lysine to crude protein ratio in the diet of 7.1 to 7.4%
  • Do not exceed the SID lysine to crude protein ratio of 6.4%

Some conditionally essential amino acids (e.g. arginine, proline, and glutamine) also play critical roles in diets with reduced crude protein levels. Glutamine is especially interesting. When supplemented in the feed, it can be used as a source of energy by the intestinal epithelium and, therefore, prevent atrophy and support nutrient absorption, resulting in better growth post-weaning (Hanczakowska and Niwińska, 2013; Watford et al., 2015)

The importance of the buffer capacity of the feed – supporting the enzymatic system

Given the move towards antibiotic reduction, this topic is more relevant than ever to nutritionists worldwide. The acid-binding capacity (also known as buffering capacity) of the feed directly affects the capacity of the stomach to digest protein. Hence, buffer capacity is of utmost importance in antimicrobial-free diets as it influences the growth of pathogenic bacteria (Lawlor et al., 2005).

In short, the acid-binding capacity is the resistance of an ingredient or complete feed to pH change. For piglet feed/feed ingredients, it is normally measured by the acid-binding capacity at pH4 (ABC-4). A higher ABC-4 equates to a higher buffering capacity. Feed with a high ABC-4 would require large amounts of gastric acid for the pH of the stomach to reach 4 and below. As the post-weaned piglet has limitations on producing and secreting acid, the stomach pH would stay high and, thus, less favorable for protein digestion.

The recommendation is to have a complete feed based on single ingredients with low ABC-4 values and to use additives that further reduce the ABC-4 value (such as organic acids). According to Molist (2020), post-weaning feed must have an ABC-4 that is lower than 250-300 meq/kg.

Talking about fiber

Dietary fibers are also known for regulating intestinal health in both humans and animals. Chen et al. (2020), for example, examined the effects of dietary soluble fibers (inulin) and insoluble fibers (lignocellulose) in weaned piglet diets for four weeks. Results showed that combining those fibers can positively influence nutrient digestibility, gut microbiota composition, intestinal barrier functions, and growth performance (table 1 ).

Effects of dietary fiber supplementation on piglet growth performance
Table 1. Effects of dietary fiber supplementation on piglet growth performance (adapted from Chen et al., 2020)

How to reduce antimicrobials? Understand the roles of piglet physiology and nutrition

Swine producers might think that “How can I reduce antimicrobial use on my farm?” and “How can I improve the performance of piglets at weaning?” are two separate questions. However, that is not always the case. Answers based on a deep understanding of physiology and nutrition dynamics help piglets overcome the challenges encountered during weaning – and, thus, lessen the need for antimicrobial interventions.

In this article, we have explored the basic principles that are the basis for ensuring the performance and health of the post-weaning piglet. Although we do not have a singular solution for eliminating antimicrobials on our pig farms, we can count on a group of robust and integrated nutritional strategies. By integrating factors ranging from management to feed additives, these solutions can improve piglet health and performance throughout their lives.

 

To know more about Gut health products click here.




How to develop phytogenic feed additives

art103 header

By Technical Team, EW Nutrition

Modern feed additives are now commonly used as a critical tool to improve animal health. Among these, phytogenic feed additives are increasingly widely adopted. Consequently, more and more products are entering the market, leaving producers to wonder how these products differ from one another and which product performs best. To better understand the benefits that phytogenic feed additives can bring to operations, one must understand the development process feed additives undergo.

develop phytogenic feed additives for chicken

Not all feed additives are born equal

Feed additives are products that are added into an animal feed to improve its value. They are typically used to improve animal performance and welfare and consequently to optimize profitability for livestock producers.

Their purpose should not be confused with that of veterinary drugs. Feed additives provide additional benefits beyond the physiological needs of the animals and should be combined with other measures to improve production efficiency. Those measures include improvements in management, selection of genetics, and a constant review of biosecurity measures.

Several categories of feed additives exist. They all have in common that they are mixed into the feed or premix or the drinking water in relatively low inclusion rates to serve a specific purpose. Examples of feed additives are organic acids, pre- and probiotics, short and medium chained fatty acids, functional yeast products, and phytogenic feed additives. Modern feed additives also blend those different additives into combination products, increasing the value of the final products.

Phytogenic feed additives are a sub-category of additives containing phytomolecules, active ingredients which originate from plants and provide a unique set of characteristics. These molecules are produced by plants to protect themselves from molds, yeasts, bacteria, and other harmful organisms. Depending on the type of molecule, phytomolecules have different properties, ranging from antimicrobial to antioxidant and anti-inflammatory.

EW Nutrition’s approach to developing Ventar D: 6 steps

The development of best-in-class phytogenic feed additives is a complex process. For Ventar D, EW Nutrition divided the process into the following steps, which can serve as a template for a successful development process:

  1. Reviewing customer needs
  2. Active ingredient selection
  3. Technical formulation
  4. Application development and scale-up
  5. Performance tests
  6. Safety and regulatory validation

Understanding customer needs

The most important point in developing a feed additive is customer-centricity. Understanding the challenges and needs of producers is crucial to developing feed additive solutions.

In a first step, additive producers need to evaluate and quantify customer needs wherever possible. This is achieved through communication and literature review: Producers, key opinion leaders, and research partners are interviewed, and their challenges are listed. In the next step, those challenges are further analyzed using scientific literature. In a final step, the customer needs are ranked according to their impact on the customer’s profitability.

customer needs

Subsequently, the minimum requirements for the new feed additive are derived. For phytogenic feed additives, this might be, for instance, something like “Improving animal performance and reducing antibiotic use while increasing profitability”. The selected key performance parameters might be, for example, feed efficiency improvements in broilers.

Marketing Research

Meeting unmet needs

Once the customer needs have been understood, the next phase of the development starts. Based on the intended mode of action, certain phytomolecules are chosen based on their described properties. In our example, this might be an antimicrobial mode of action that targets enteropathogenic bacteria in broilers, supporting gut health.

Meeting unmet needs

In this in-vitro process, the selected individual compounds will be tested for their respective antimicrobial efficacy using MIC and MBC testing. Those tests are run using high-purity compounds.

features test

The tests will be conducted using various relevant field strains like E. Coli, S. enterica or C. perfringens. In the next step, the testing will be repeated with commercially available ingredients. The most promising compounds will be tested in more complex mixtures.

Modern phytogenic feed additives are based on the concept of combining different phytomolecules to attack bacteria in diverse ways, with their antimicrobial effects being multi-modal. This mode of action is crucial because it makes it very unlikely that bacteria can develop resistance to combinations of phytomolecules, as they do to antibiotics.

Selecting the right form of application

Feed processing is often a challenge for additives. Many phytomolecules are highly volatile and prone to volatilization and high temperatures. Especially non-protected phytogenic products are negatively affected by high pelleting temperatures and long retention times of the feed in the conditioner. The results are losses in activity.

features test

Therefore, the development of appropriate delivery systems is a preemptive method to ensure the release of the effective compounds where they should be released – in the gut of the animals. Those delivery systems can utilize emulsifiers when applying the additive via the water for drinking, or encapsulation technologies when the new additive is administered via feed.

Due to the importance of mixability, flowability, and pelleting stability for the performance of the feed additives, the exact types of emulsifiers, carrier, and technologies used in their production is often considered corporate intellectual property.

The importance of in-vivo evaluations

In one of the last steps of the development, the newly developed feed additive prototype needs to prove its safety and efficacy in the animal. Hence the need to run evaluation studies to confirm the mode of action chosen in the initial lab phase. Typically, the additive will be tested in the target species in in-house and external research institutes.

farm test

For a phytogenic feed additive, that might entail comparing its effect on body weight gain, feed efficacy, and gut health against different control groups. Additionally, the newly developed feed additive might be compared to existing additives to get a better understanding of its capabilities.

safety test

Dose-finding studies are conducted to verify the chosen dose recommendation and additional overdosing studies are conducted to prove the safety of the additive for both animals and consumers. In certain markets or regulatory environments, additional studies might be required. Those can contain environmental safety assessments or proof that the new additive does not create residues in animal products.

Case study: Ventar D

For Ventar D, the process followed these steps meticulously, in agile iterative development loops that went from the customer need to formulation, testing, scale-up, in-house and external trials, and finally production.

These steps ensured that the final product that reaches the customer’s doorstep delivers on the expectations – and more.

Case study: Ventar D  

Choose your phytogenic products wisely

The plethora of (phytogenic) feed additives in the market leaves producers with many options to choose from. However, only scientifically developed feed additives can be relied upon to optimize both animal health and production profitability. It is important to select reliable feed additive producers who developed their phytogenic product with the customers’ challenges in mind and went through all the steps necessary to create a high-performing and safe additive.




Phytogenic additives: An ROI calculation

shutterstock 1443136526 pullet scaled e1635251702725

By Ruturaj Patil, Global Product Manager – Phytogenics, EW Nutrition

Global trade in agricultural products has a direct impact on the added value in regional broiler production. Due to fluctuating meat and feed prices, a tight profit margin can melt away quickly. Changes such as the use of cheaper raw materials, implemented to deal with reduced margins, may negatively affect flock health, creating a vicious cycle: If the flock also experiences increased disease pressure, the financially critical situation worsens.

Phytogenic additives: An ROI calculation

What can the right phytogenic feed additive deliver for broiler producers?

It is essential to improve broiler gut health, as only healthy birds will perform and allow producers to be profitable. Producers can maintain flock performance through preventive management measures, a consistent hygiene concept, and the use of high-quality feed. For unproblematic flocks, the same measures also positively affect profit, generating a healthy return on investment (ROI).

What affects your return on investment?

In broiler production, the cost of feed is highest, with a share of 60 – 70 % of the total production costs. The proportion tends to be higher in markets that rely on importing feed raw materials (Tandoğan and Çiçek, 2016).

Let us take an example: With a compound feed price of 300 € / t as the basis, an increase of 10 € / t results in a profit reduction of 0.016 € / kg live weight. On the other hand, an improvement in feed conversion from 1.60 to 1.55 results in a financial advantage of 0.015 € / kg live weight. The best possible feed efficiency is always desirable to keep production costs low.

Another risk factor for high-yield broiler production lives in the poultry intestines: the most significant “invisible” losses result from subclinical necrotic enteritis (Clostridium perfringens). This disease worsens the feed conversion on average by 11 % (Skinner et al., 2010). In the previous example, this would reduce feed efficiency from 1.60 to 1.78 points and reduce the contribution margin by 0.054 € / kg live weight. In addition,  a live weight reduction of up to 12 % can be observed (Skinner et al., 2010). It is, therefore, critical to stabilizing gut health to reduce the risk of subclinical necrotic enteritis.

Practice prevention for a secure return on investment

The prophylactic use of antibiotics in compound feed was a well-known reality for decades. With the EU-wide ban on the use of antibiotic growth promoters, the occurrence of multi-resistant bacteria, and a globally increased demand for antibiotic-free chickens, producers now have had to cut down on antibiotic use.

For this reason, a lot of research has been conducted into alternative measures for maintaining good broiler health. Studies have confirmed that setting up a comprehensive hygiene concept to reduce the formation of biofilms on stable surfaces and reduce the recirculation of pathogens is a solid basis. At every production stage, irregularities can be detected through a meticulous control of performance parameters and illness symptom-centered health monitoring. Diseases can either be avoided or at least recognized earlier through targeted measures, and treatment can be carried out more efficiently.

broiler performanceA thorough hygiene concept and careful monitoring at every production stage are key to ensuring broiler performance.

Feed additives for intestinal stabilization

Hygienically impeccable compound feed is the wish of every animal producer to promote the development of a balanced intestinal flora. However, the quality of the available raw materials is subject to fluctuations and can therefore not be 100 % anticipated. Consequently, producers are now commonly balancing these uncertainties by using feed additives, which positively influence the intestinal flora. These products must prove their positive effects in scientific studies before they can be used in practice.

An effective solution: Encapsulated phytogenic feed additives

Studies have found that certain phytomolecules, which are secondary plant metabolites, can support broiler gut health. By stimulating digestive enzyme activities and stabilizing the gut microflora, feed utilization improves, and broilers are less prone to developing enteric disorders (Zhai et al., 2018).

The encapsulation of these naturally volatile substances in a high-performance delivery system is critical for the success of a phytogenic feed additive. This protective cover, which is often a simple coating, provides good storage stability in many cases. However, in addition to the high temperatures, mechanical forces also act on these coatings during pelleting. The combination of pressure and temperature can break the protective coating of the product and lead to the loss of active substances.

A complete solution: How Ventar D maximizes your ROI

Because of the difficulties mentioned, the use of modern delivery system technologies is therefore necessary. EW Nutrition has many years of experience in the development of phytogenic products. Due to an original, innovative delivery system technology, Ventar D can offer high pelleting stability for optimal improvement of animal performance.

In particular, the positive influence of the phytogenic feed additive Ventar D on intestinal health under increased infection pressure was assessed in multiple studies. In two studies carried out in the United Kingdom, birds were challenged by being housed on used litter harvested from a previous trial. Moreover, increasing levels of rye were introduced into the diet, adding a nutritional challenge to provoke an increased risk of intestinal infections in the broilers. The use of 75 g of Ventar D per t compound feed increased the EPEF (European Production Efficiency Factor) by 4.1% and feed efficiency from 1.63 to 1.60.

A complete solution: How Ventar D maximizes your ROI

With Ventar D use at 100 g / t compound feed under comparable conditions, EPEF increased by 8.9 %, and feed efficiency improved by 5 points (0.05), compared to a non-supplemented control group (NC).

Another study was carried out in the USA. In addition to performance parameters, data on intestinal health were also recorded. In the group fed with Ventar D (100 g / t compound feed), 50 % fewer necrotic enteritis-related lesions of the intestinal wall were found after 42 days. Compared to the group fed with Ventar D, the broilers of the control group showed a performance decrease of 11.8 % with an 8% lower final fattening weight and a 3 points poorer FCR.

Necrotic enteristis lesion scores

Based on the results of the above studies, the ROI for Ventar D due to the improvement in feed efficiency by 3 and 5 points could be 1:3.5 and 1:6.5, respectively. Similarly, the net returns for using Ventar D could be 0.007 and 0.013 € / kg live weight, given the 3 and 5 points improvements in feed efficiency. The ROI for Ventar D use could be even higher thanks to additional benefits such as improvements in litter condition and foot pad lesions, reduced veterinary cost, etc., depending on the prevailing challenges.

The future of feeding is here

The first study results for Ventar D underscore that, if combined and delivered right, phytomolecules can transform broiler performance from inside the gut. Ventar D’s stable delivery system ensures a constant amount of active molecules in targeted intestinal sites and, therefore, supports a favorable intestinal flora. With Ventar D supplementation, subclinical intestinal infections due to C. perfringens or other enteric bacteria can be very well kept in check, ensuring improved broiler productivity and production profitability.

 

References

Skinner, James T., Sharon Bauer, Virginia Young, Gail Pauling, and Jeff Wilson. “An Economic Analysis of the Impact of Subclinical (Mild) Necrotic Enteritis in Broiler Chickens.” Avian Diseases 54, no. 4 (December 1, 2010): 1237–40. https://doi.org/10.1637/9399-052110-reg.1.

Tandoğan, M., and H. Çiçek. “Technical Performance and Cost Analysis of Broiler Production in Turkey.” Revista Brasileira de Ciência Avícola 18, no. 1 (2016): 169–74. https://doi.org/10.1590/18069061-2015-0017.

Zhai, Hengxiao, Hong Liu, Shikui Wang, Jinlong Wu, and Anna-Maria Kluenter. “Potential of Essential Oils for Poultry and Pigs.” Animal Nutrition 4, no. 2 (June 2018): 179–86. https://doi.org/10.1016/j.aninu.2018.01.005




EW Nutrition launches Pretect D to support poultry gut health during challenging periods

shutterstock 766401004 scaled

VISBEK, 28 September – EW Nutrition announces the launch of a novel gut health solution for poultry. Pretect D, a proprietary blend of phytomolecules, helps maintain bird performance and farm profitability.

Trials indicate that Pretect D offers natural support even during Eimeria-related challenges, making it an effective addition to programs focused on gut health issues.

“EW Nutrition is a front runner when it comes to innovations driving lower use of antibiotics and harmful chemicals in the animal production industry,” says Michael Gerrits, Managing Director. “The introduction of Pretect D signifies our commitment to helping customers make livestock production more sustainable through best-in-class natural solutions.”

Research with Pretect D conducted around the globe, in research institutes and under commercial conditions, evidenced improved body weight and lower feed conversion rate. EW Nutrition is also following up on initial results indicating significant oocyst count reduction.

“Poultry producers are affected by reduced animal performance and high costs for preventive and therapeutic control,” says Madalina Diaconu, Product Manager for Pretect D. “What our product brings to the market is an ability to support the natural defenses of birds. We’re also investigating our product’s ability to impair the growth cycle of the Eimeria population.” Pretect D is developed to be used in combination with vaccines, ionophores and chemicals, as part of the shuttle or rotation program.

 

About EW Nutrition

For the global animal production and feed industries, EW Nutrition offers innovative, comprehensive solutions for gut health, feed quality, pigmentation, digestibility, on-farm performance and more.

Headquartered in Germany, with R&D and manufacturing facilities around the world, EW Nutrition owns the entire value chain, from development and scale-up to production, distribution, and support in 90+ markets.

 




What poultry producers need to know about coccidiosis control

art65 header scaled

By Madalina Diaconu, Product Manager Pretect D, and Dr. Ajay Awati, Global Category Manager Gut Health & Nutrition, EW Nutrition 

 

Coccidiosis is one of the most devastating enteric challenge in the poultry industry costing over over 14 billion US$ per year (Blake et al., 2020). In the early days of  intensive poultry production, outbreaks of Eimeria tenella, were most destructive. Eimeria tenella is a coccidia species that causes severe haemorrhages and hypovolemic shock, leading to a fatal outcome for the affected bird. 

Poultry producers need to control the performance and welfare issues caused by subclinical coccidiosisPoultry producers need to control the performance and welfare issues caused by subclinical coccidiosis

Understanding and managing coccidiosis in poultry

However, today, subclinical coccidiosis accounts for even more of production losses due to intestinal cells injuries: lower body weights, higher feed conversion rates, lack of flock uniformity, failures on skin pigmentation and, at the end mortality. Variation in the supply and quality of animal feed exacerbates the issue and compromises farm profitability even more. To tackle this challenge, we need to understand the basics of coccidiosis control in poultry and what options producers have to manage coccidiosis risks.

From Eimeria infection to disease

Coccidiosis is a disease caused by protozoan parasites, mainly of the genus Eimeria, that are located in the small and large intestines. Being very resistant and highly contagious, these protozoa are easily transmitted by various routes (via feed, litter, water, soil, material, insects, and wild animals).

Coccidia are present in all livestock species. However, the infection is particularly severe in poultry. The health consequences can be significant: loss of appetite, reduction in feed intake, increased FCR, enteritis, hemorrhagic diarrhea, and mortality. The most common species of Eimeria in broilers are: E. acervulina, E. mitis, E. maxima, E. brunetti, E. necatrix, E. praecox, and E. tenella. They are widely found in broiler productions across the globe (McDougall & Reid, 1991).

Sporulated oocyst of Eimeria maxima and E. Acervulina Figure 1: Sporulated oocyst of Eimeria maxima and E. Acervulina (40 x)

The pathogenesis of infection varies from mild to severe and is largely dependent on the magnitude of infection. Coccidiosis outbreaks are related to multiple factors that, together, promote a severe infestation in the farm.

Within poultry, the highest economic impact is in broilers, where the most common species of Eimeria are E. acervulina, E. maxima, E. tenella and E. necatrix, which all show high virulence. However, pathogenicity is influenced by host genetics, nutritional factors, concurrent diseases, age of the host and the particular species of the Eimeria (Conway & McKenzie, 2007).

Interaction of factors that promote coccidia outbreaksFigure 2: Interaction of factors that promote coccidia outbreaks

The Eimeria infection starts with the ingestion of protozoa that are at a sporulated stage. Once inside the gut, the protozoa liberate the sporozoites. This infective form can get into enterocytes and then begin a massive reproduction, killing thousands of intestinal cells. (Olabode et al., 2020; Shivaramaiah et al., 2014)

Eimeria spp. life cycleFigure 3: Eimeria spp. life cycle

The reproduction potential depends on the coccidia species. E. acervulina, E. mitis and E. praecox have the highest reproduction rate. This characteristic is closely related to their short life cycle.

In broilers, coccidiosis usually occurs after 21 days of age. The infection spreads gradually from day 1 already, depending on species of Eimeria and their virulence. A typical progression of coccidiosis in broilers is shown in Figure 4.Typical development of a coccidia infection in relation to broiler feed phasesFigure 4: Typical development of a coccidia infection in relation to broiler feed phases

Coccidiosis control in poultry: Strategy guidelines

The intrinsic characteristics of coccidiosis makes this parasite unique and many times frustrating to control. Resistance to available coccidiostats makes this task even harder.  Good farm management, litter hygiene, and the use of control coccidiosis programs such as shuttle and rotation are functional measures to prevent clinical coccidiosis. Successful control strategies specifically recognize the importance of monitoring, use anticoccidial drugs wisely, and include vaccines where applicable.

Monitoring

The first step is to establish a strict monitoring program in all stages of production, including the feed mill. It is important to verify that therapeutics are included in the feed in an adequate form and quantity, and that the follow-up in the field takes place.

Field monitoring should be frequent and in line with the operation’s coccidiosis management program. Field monitoring is a complementary work that collates clinical, necropsy, and faeces findings to closely track the disease situation.

Coccidiosis control in poultry operations needs to include rigorous monitoringCoccidiosis control in poultry operations needs to include rigorous monitoring

Anticoccidial drugs

Since the middle of the 20th century, chemotherapeutic agents have offered the best way to control coccidia. However, unbridled use of anti-coccidial drugs and the emergence of the new resistant field strains of coccidia have made it increasingly challenging to control coccidiosis with commonly available coccidiostat drugs.

The coccidiostats have been classified in two groups: ionophores, molecules obtained from microbiological fermentation, and chemicals, synthetic compounds. The mode of action of ionophores is to interfere with the membrane ion exchange, killing the extracellular stages (sporozoites and or merozoites) as they expend energy to maintain the osmotic balance. Chemical compounds can have an anticoccidial effect even on extracellular and intracellular stages (Sumano López & Gutiérrez Olvera, 2005).

However, resistance development is limiting their effectiveness, and certain compounds cannot be used in older birds or in hot environments. Moreover, government regulations often include anti-coccidial drugs in bans on antibiotics use. This does not mean that these drugs are not crucial to controlling this disease, but it is important to use alternative tools: they help make a coccidiosis control program not only less dependent on anticoccidial drugs but also more robust.

Vaccines

There are two commercial kinds of coccidia vaccines; the first one uses natural strains. These Eimeria are selected from field outbreaks, show a medium pathogenicity, and allow for a controlled replication of a coccidia infection. The second kind of vaccines include attenuated strains; these are precocious strains and birds usually show low or no post-vaccinal reactions.

The management of coccidia vaccines is the principal challenge for using this tool to control coccidia. Special vaccination training is required at the hatchery, which then needs a follow-up on the farm. In the field, this follow-up and the alignment of all the protocols has proven challenging for many producers.

Managing coccidiosis in poultry: Next steps

The limitations chemotherapy and vaccines have led to a surge in the quest for effective  natural solutions. Recent research into plant-derived phytochemicals shows that these compounds have properties that make them an interesting tool against coccidiosis (cf. Cobaxin-Cárdenas, 2018). Knowledge, research, and technological developments are now ready to offer solutions that can be an effective part of coccidia control programs. These natural solutions create opportunities to make poultry production more sustainable by reducing dependency on harmful drugs.

References

Bafundo, K.W., L. Gomez, B. Lumpkins, G.F. Mathis, J.L. McNaughton, and I. Duerr. “Concurrent Use of Saponins and Live Coccidiosis Vaccines: The Influence of a Quillaja and Yucca Combination on Anticoccidial Effects and Performance Results of Coccidia-Vaccinated Broilers.” Poultry Science 100, no. 3 (2021): 100905. https://doi.org/10.1016/j.psj.2020.12.010.

Blake, Damer P., Jolene Knox, Ben Dehaeck, Ben Huntington, Thilak Rathinam, Venu Ravipati, Simeon Ayoade, et al. “Re-Calculating the Cost of Coccidiosis in Chickens.” Veterinary Research 51, no. 1 (September 14, 2020). https://doi.org/10.1186/s13567-020-00837-2.

Cobaxin-Cárdenas, Mayra E. “Natural Compounds as an Alternative to Control Farm Diseases: Avian Coccidiosis.” Farm Animals Diseases, Recent Omic Trends and New Strategies of Treatment, March 21, 2018. https://doi.org/10.5772/intechopen.72638.

Conway, Donal P., and M. Elizabeth McKenzie. Poultry Coccidiosis: Diagnostic and Testing Procedures. Ames, IA, IA: Blackwell Publishing, 2007.

McDougall, L. R., and W. M. Reid. “Coccidiosis.” Chapter. In Diseases of Poultry, edited by B. W. Calnek, H. W. Yoder, W. M. Reid, C. W. Beard, and H. J. Barnes. Ames, IA: Iowa State University Press, 1991.

Olabode, Victoria Bose, Dashe Yakubu Gunya, Umaru Mada Alsea, Tobias Peter Pwajok Choji, and Israel Joshua Barde. 2020. “Histopathological Lesions of Coccidiosis Natural Infestation in Chickens”. Asian Journal of Research in Animal and Veterinary Sciences 5 (2), 41-45. https://www.journalajravs.com/index.php/AJRAVS/article/view/30090.

Shivaramaiah, Chaitanya, John R. Barta, Xochitl Hernandez-Velasco, Guillermo Téllez, and Billy M. Hargis. “Coccidiosis: Recent Advancements in the Immunobiology of Eimeria Species, Preventive Measures, and the Importance of Vaccination as a Control Tool against These Apicomplexan Parasites.” Veterinary Medicine: Research and Reports 2014, no. 5 (April 28, 2014): 23–34. https://doi.org/10.2147/vmrr.s57839.

Sumano López, Héctor, and Gutiérrez Olvera Lilia. Farmacología Clínica En Aves Comerciales. México: UNAM, Departamento de Fisiología y Farmacología, 2005.




ABF poultry production: How to keep coccidiosis in check

art74 header

By T.J. Gaydos

Coccidiosis control consists of programs, including ionophores, chemical coccidiostats, vaccines, and gut health-promoting natural products. Sometimes, these are combined (Noack, Chapman, and Selzer, 2019). Antibiotic-free (ABF) production requires new approaches – this article will look at how different solutions can be successfully implemented.

Meticulous coccidiosis management in ABF productions is crucial to safeguard animal welfare and performance.

What makes up a successful coccidiosis control program for ABF systems?

When managing a poultry program without antibiotics in the U.S., where ionophores are classified as antibiotics, the only available tools for coccidiosis control are vaccines, chemical coccidiostats, and natural products supporting gut health during challenging times.

  • The use of a chemical-only program is possible and often successful. Still, the choice of chemicals is limited, and the risk of building resistance must always be considered and managed through the appropriate rotation of active ingredients.
  • A second option is a coccidiosis vaccine with or without chemical coccidiostats. This is an excellent long-term option but the most difficult to manage.
  • A third effective option is a coccidiosis vaccine combined with the use of phytomolecule-based solutions contributing to the coccidiosis control program and delivering improved gut health.

What do most ABF newcomers do?

When making the transition from conventional to ABF production, broiler producers usually try:

  1. A chemical coccidiostat program,
  2. A bio-shuttle program: a coccidiosis vaccine, followed by a chemical coccidiostat, or
  3. Phytomolecule-based feed additives; typically, in combination with a coccidiosis vaccine or chemical program.

When the operation can master managing the coccidiosis vaccine and other husbandry challenges, the optimal solution is the combination of vaccination and phytomolecule-based feed supplements.

Why a combination?

A coccidiosis control program based on vaccination begins in the hatchery and continues through live production. Its success relies on many moving parts working in sync to produce the desired result of early uniform immunity to coccidiosis. Phytomolecule-based products additionally can support the animals in terms of gut health, oxidative balance, and immunity.

Vaccination success depends on attention to detail

If one decides to use vaccination for coccidiosis control, the following points must be considered to achieve high effectiveness.

Vaccine storage – the right temperature is crucial

Proper storage is essential for all vaccines. In general, coccidiosis vaccines should be stored between 2° to 7°C (35° to 45°F), but optimally, one asks the vaccine manufacturer for product-specific directions. Coccidiosis vaccines must not freeze. Freezing will severely damage or kill the oocysts, thus significantly reducing efficacy. It is also important to ensure that there are no cold spots in the refrigerator. Hence, vaccines should be stored in the middle of a shelf with air space around or in a foam-insulated place inside the fridge.

For monitoring the temperature, an analog high/low thermometer should be placed by the vaccine. The temperature should be recorded, and the thermometer reset daily. To minimize the risk of administering a frozen vaccine, it is recommended to put freeze indicators outside the boxes. If, despite all these measures, vaccines are suspected to have frozen, segregate the suspect product and contact the supplier for assistance.

Vaccine administration – mind an even distribution for all steps

The goal of vaccination is to build early and uniform immunity in all chickens, which is achieved by exposure to repeated cycles of coccidia replication in the intestine.

1.      Even distribution of the oocysts in the vaccine

It is essential to ensure that all oocysts flow from the bottle into the distribution jug when mixing the vaccine. The oocysts should be well-mixed and then must be constantly agitated to remain suspended in solution. The most common way to suspend oocysts is to use a small air pump to bubble the vaccine, creating turbulence.

2.      Even spraying of the vaccine onto the chicks

The next important step is to ensure that the chicks are evenly covered with the vaccine. When in doubt, run a chick box through the spray cabinet, collect the nozzles’ output, and measure the volume sprayed. To check the spray pattern, set a piece of clear hard plastic on top of the pegs in the chick basket and run the box through the spray cabinet. Evaluate the spray pattern on the plastic sheet and adjust as needed to ensure an even spraying. The spray pattern should be checked every time a new batch of vaccines is mixed.

Even spraying of coccidiosis vaccine can be easily tested using a clear plastic sheet.

3.      A similar amount of vaccine intake for all chicks

Coccidiosis vaccines must be preened and consumed to be effective. Adding a dye to the spray compatible with the vaccine will help stimulate the birds to preen. A well-lit and temperature-controlled processing and holding area will promote preening behavior. Tongues should be checked regularly to ensure that chicks consume the vaccine. At a minimum, check ten birds per basket and ten baskets per lot. More than 98% of birds should have evidence of vaccine consumption within 10-15 minutes post-vaccination.

Chick vitality is a critical success factor in an ABF program. Healthy chicks perform better in the field. In the context of a coccidiosis vaccine, they are more apt to preen, more likely to consume food and water quickly, and less likely to excessively pick at the litter.

A dye helps to evaluate if the coccidiosis vaccine was evenly sprayed across all chicks.

Uniform immunity through effective farm management

A successful coccidiosis vaccination program achieves uniform immunity against coccidia, which slowly develops from the hatchery. For this purpose, birds must be evenly spread throughout all stages of growth to seed the litter evenly with oocysts and to have even coccidiosis pressure in all parts of the house.

Time management allows even immunization

Birds should be turned out from half to full house between 9 and 11 days. This schedule allows the birds to excrete the first round of oocysts and for the oocysts to sporulate and be consumed by the birds.

The birds need to be moved to full house before they secrete the second round of oocysts. This will allow the oocysts to be spread uniformly in the house. Coccidia reproduce exponentially and the second round of oocyst production is significantly more numerous than the first.

It is possible to brood birds in the full house while on coccidiosis vaccine. Still, it is complicated to manage the coccidiosis cycling because bird density is generally too low to ensure that birds effectively cycle the vaccine strain oocysts.

Litter consistency is decisive

Litter management is essential to control the cycling of coccidiosis because one stage of the life cycle of coccidia occurs in the litter. Litter moisture of 25% is ideal. When litter is squeezed in a fist, it should briefly form and immediately break apart. If it stays formed, it is too wet. If the litter is free-flowing and dusty, it is too dry for adequate sporulation.

Non-antibiotic supplements support coccidiosis management

Managing coccidiosis cycling requires attention to detail and is probably the most challenging part of adequately managing an ABF program. All farms are not equal and need to be supervised according to their specific needs. The use of non-antibiotic feed and water additives can help control coccidiosis and other enteric diseases.

Some non-antibiotic supplements have anticoccidial (e.g. amprolium, saponins, tannins) or antibacterial (e.g., plant extracts) activity. When used correctly, these may improve the performance of birds in a vaccination or chemical-based coccidiosis control program. Other non-antibiotic alternatives such as probiotics, prebiotics, organic acids, and yeast cell wall extracts have been shown to improve gastrointestinal health. The combination of excellent animal husbandry and the correct feed/water additive program is the key to success.

References

Noack, Sandra, H. David Chapman, and Paul M. Selzer. “Anticoccidial Drugs of the Livestock Industry.” Parasitology Research 118, no. 7 (2019): 2009–26. https://doi.org/10.1007/s00436-019-06343-5.




How to achieve sustainable antibiotic-free broiler production

art64 new header photo scaled

by Predrag Persak, Regional Technical Manager North Europe, EW Nutrition

The main sustainability challenge for broiler production lies in securing enough high-quality, nutritious, safe, and readily available food at a reasonable cost. At times, feed ingredients have to be included that are not nutritionally ideal and might compromise one’s broilers’ health and wellbeing. However, counteracting this threat with prophylactic antibiotics is not acceptable: We must minimize the use of antibiotics to mitigate antimicrobial resistance. The way forward is to go beyond static and linear nutritional value-to-price thinking. A dynamic nutritional strategy focusing on the interdependencies between ingredients, gut, microbiome, and digestion, enables sustainable ABF broiler production.

Sustainable ABF broiler production requires a dynamic, gut health-oriented nutritional strategy

Sustainability vs. ABF production – is there a trade-off?

The United Nations’ 1987 Brundtland report offers a clear definition of sustainability as “development that meets the needs of the present without compromising the ability of future generations to meet their own needs.” “Ability” includes the availability of resources – and in broiler production, which is one of the most efficient livestock productions, resources have always been a top priority. As a constantly evolving industry, broiler production has been quick to adopt sustainability into its management strategies. The use of the resource that is antibiotics, however, poses particular challenges.

Humans and animals depend on antibiotics to fight microbial infections. It is essential to maintain their efficacy so that future generations can lead healthy lives. Antibiotic efficacy is under threat from the development of antimicrobial resistance, which emerges from overuse and misuse in both human and veterinary medicine. Across the globe, broilers are still raised with the assistance of antibiotics. Either for disease therapy, to prevent disease occurrence, and still, in some parts of the world, to enhance performance. Driven by regulatory and consumer demands, broiler production with minimal or no use of antibiotics is rapidly gaining importance.

The challenges of antibiotic-free broiler production

ABF systems encounter numerous challenges since production requirements change drastically. Stock density must be lower; it takes longer to reach the desired weight; and more feed is needed to produce the same amount, with a higher risk of morbidity and mortality (Cervantes, 2015). The latter can result in more birds needing treatment with medically important antimicrobial drugs. All those challenges need to be overcome by adopting suitable strategies related to nutrition, genetics, management, biosecurity, welfare, and food safety.

As animal nutritionists, our focus lies on nutrition, feed, feed materials, additives, feed processing, feeding, and their (positive or negative) influence on the sustainability of ABF broiler production. However, we cannot look at these dimensions of production as a separate process. They are linked in the whole food chain and are affected by changes that happen in other related parts. An obvious example is feed production, which has an enormous impact on the overall sustainability of ABF broiler production:

  • Due to raw material shortages, diets are becoming ever more complex, containing more single feed ingredients. For some of them, we need a better understanding of their impact on ABF broiler production (e.g., sunflower, rapeseed, beans, lupins).
  • The nutritional composition of raw materials changes due to limitations in fertilizer use, and variability within the same raw material group is expected to increase.
  • New food waste-reducing feed materials can enhance feed security but also require nutritional profiling to integrate them into diets.
  • Local feed material production in humid and warm environments can introduce various pathogens into the feed/food chain.
  • Increases in known and the emergence of new antinutrients and feed components that impair animal health, performance, and feed efficiency.
  • Sustainability-driven pesticide reduction raises concerns about mycotoxins contaminating feed ingredients.
  • Nutrient reduction to support gut health and, primarily, lower the excretion of nitrogen and phosphorous, negatively affects growth, nutritional standards, and the ability to freely select feed materials to include in broiler diets.
  • The value (of which price is also part) of raw materials will be compromised, due to availability and nutritional variability.

Mycotoxin contaminated-feed can damage production animals' performance, health, and welfareMycotoxin contaminated-feed can damage production animals’ performance, health, and welfare

When striving for a sustainable ABF broiler production approach, the possibility for errors becomes higher, while the error margin becomes smaller. The solution lies in helping the animals to mitigate the impact of stressors by focusing on the interaction of ingredients, gut, microbiome, and digestion. It is a holistic approach centered on gut health. Keeping the intestines BEAUTIful will help you produce in challenging conditions without the use of antimicrobials.

Keep the broiler gut BEAUTIful and resilient to stress

The BEAUTIful formula captures the six areas producers need to target for supporting broiler gut health:BEAUTI stands for barrier, enzymatic digestion, absorption, united microbiome, transport, and immunity

Barrier

If it’s working correctly, the effective gatekeeper knows what gets in and what stays out. When the barrier function is compromised due to stress, pathogens can cause infections, disrupt health, and negatively impact broiler immunity. Necrotic enteritis, femoral head necrosis, and bacterial chondronecrosis with osteomyelitis (BCO) are common diseases that affect today’s broiler production (Wideman, 2015). As the source of nutrients, feed serves as a modulator of various physiological functions in the intestinal tract, including intestinal barrier function.

Enzymatic digestion

The gut is where endogenous and exogenous enzymes perform their hydrolysis functions to break down complex nutrients into the parts that can be used either by the intestinal tissue itself or for the whole animal. One part of hybrid enzymatic digestion is the fermentation by commensal microbes, in which complex materials form end-products of high biological values (such as short-chain fatty acids, SCFA).

Absorption

Maintaining the gut’s resorptive capacity is essential to secure the total intake of digested nutrients. Otherwise, pathogenic bacteria might use the excess nutrients to grow, form toxins, and affect the birds’ health and productivity.

United microbiome

The intestine of a broiler chicken is colonized by more than 800 species of bacteria and other inhabitants, such as viruses and simple organisms that are still unknown. By competitive exclusion and secretion of bacteriocins (volatile fatty acids, organic acids, and natural antimicrobial compounds), commensal bacteria keep the host safe from an overgrowth of dangerous bacteria (e.g., Salmonella, Campylobacter, and Clostridium perfringens). The fine-tuned diversity in the intestinal flora and balance in all interactions between it, the host, and the ingesta are needed for birds to stay healthy and perform well.

Transport

Birds’ digestive tract volumes are smaller than those of mammals with similar body weight. This means that they achieve more efficient nutrient digestion in a shorter retention time, averaging between 5 and 6 hours. Passing the small intestine usually takes around 3 hours, of which 1 hour is spent in the duodenum and jejunum. Transport times are affected by the feeding system and the extent to which material enters the caeca. Reflux of material from the distal to the proximal small intestine is an important feature that helps digestion and maintenance of a healthy gut.

Immunity

The intestinal microbiota is critically important for the development and stimulation of the immune system. The intestine is the key immunological organ, comprised of myeloid and lymphoid cells, and a site for producing many immune cell types needed to initiate and mediate immunity. Together with the microbiome, dendritic cells induce antigen-specific responses and form immunoglobulin A, which works in the intestinal lumen.

Natural gut health solution for sustainable ABF broiler production

In practice, supporting broiler gut health requires a holistic approach that includes natural feed additive solutions. Phytomolecules are compounds that certain plants develop as defenses mechanisms. Phytomolecules-based solutions should feature prominently in sustainable ABF broiler production approaches due to their advantageous properties:

Enhance digestion, manage variability

Sustainability necessitates efficient resource utilization. Digestion support needs to be a priority to use the available feed in its entirety. This is particularly important if antibiotics use needs to be minimized: a maximum of nutrients should be utilized by the animal; otherwise, they feed potentially harmful bacteria, necessitating antibiotic treatments. Enhancing digestibility is the focus when we are dealing with variable feed materials or feed changes that represent stress to the animal. Selected phytomolecules have proven efficient at improving performance due to enhanced digestion (Zhai et al. 2018).

Work on microbiome and pathogens

The antimicrobial activity of certain phytomolecules can prevent the overgrowth of pathogens in the gastrointestinal tract, thereby reducing dysbacteriosis (Liu et al., 2018) and specific diseases such as necrotic enteritis. Studies on broilers show that they also reduce the adhesion of pathogens to the wall of the intestine. Certain phytomolecules even possess antimicrobial characteristics against antibiotic-resistant pathogens.

Keep gut integrity

Phytomolecules help maintain tight junction integrity, thus preventing leaky gut (Li et al., 2009). As a result, the potential flow of bacteria and their toxins from the gut lumen into the bloodstream is mitigated. Their properties thus make phytomolecules a promising alternative to the non-therapeutic use of antibiotics. 

Trial results: Phytomolecules enhance broiler gut health

To test the efficacy of phytomolecules, we conducted a large-scale field study in Brazil, under practical conditions. The focus was on growth performance, and no growth-promoting antibiotics were used. Lasting 5 months, the trial involved more than 2 million broilers. The birds were divided into a control and a trial group, with two repetitions per group. Both groups were fed the standard feed of the farm. The trial group additionally received 100g of Activo per MT in its finisher feed for 3 weeks. The study clearly shows that Activo supplementation improves performance parameters (daily weight gain, average total gain, and improved feed efficiency), which resulted in a higher production efficiency factor (PEF):

  • Activo groups had a 3 % higher average daily weight gain and reached their slaughtering age earlier
  • The final weight of Activo groups was about 2.5 % higher than in the control group
  • With a 2 points better feed conversion, the animals of the Activo group achieved a 13.67 points higher PEF

Figure 1: Broiler performance results, Activo vs. non-supplemented control group Figure 1: Broiler performance results, Activo vs. non-supplemented control group 

Conclusion

Antibiotic-free broiler production is a challenging endeavor: producers need to maintain animal welfare and keep up efficiency while making farming profitable. Over time, these challenges will affect producers even more as sustainability requirements increase across all parts of the broiler production chain. On top of that, coccidiostats, which are essential for efficient broiler production, are increasingly being questioned, which will require concerted research into feed additive solutions.

To make sustainable ABF broiler production the norm, it is unavoidable to adopt suitable strategies related to nutrition, genetics, management, biosecurity, welfare, and food safety. Effective, scientifically and practically proven tools already exist: Thanks to their positive impact on intestinal health, phytomolecules reliably support sustainable broiler production without antibiotics.


References

Cervantes, Hector M. “Antibiotic-Free Poultry Production: Is It Sustainable?” Journal of Applied Poultry Research 24, no. 1 (2015): 91–97. https://doi.org/10.3382/japr/pfv006.

Li, Y., H.Y. Cai, G.H. Liu, X.L. Dong, W.H. Chang, S. Zhang, A.J. Zheng, and G.L. Chen. “Effects of Stress Simulated by Dexamethasone on Jejunal Glucose Transport in Broilers.” Poultry Science 88, no. 2 (2009): 330–37. https://doi.org/10.3382/ps.2008-00257.

Liu, ShuDong, MinHo Song, Won Yun, JiHwan Lee, ChangHee Lee, WooGi Kwak, NamSoo Han, HyeunBum Kim, and JinHo Cho. “Effects of Oral Administration of Different Dosages of Carvacrol Essential Oils on Intestinal Barrier Function in Broilers.” Journal of Animal Physiology and Animal Nutrition 102, no. 5 (2018): 1257–65. https://doi.org/10.1111/jpn.12944.

Wideman, Robert F. “Bacterial Chondronecrosis with Osteomyelitis and Lameness in Broilers: a Review.” Poultry Science 95, no. 2 (2016): 325–44. https://doi.org/10.3382/ps/pev320.

Zhai, Hengxiao, Hong Liu, Shikui Wang, Jinlong Wu, and Anna-Maria Kluenter. “Potential of Essential Oils for Poultry and Pigs.” Animal Nutrition 4, no. 2 (2018): 179–86. https://doi.org/10.1016/j.aninu.2018.01.005.




Piglet Nutrition Scenarios for AGP Removal

piglets farm scaled

 

Over the past 60 years, antibiotics have played an essential role in the swine industry as a tool that swine producers rely on to control diseases and to reduce mortality. Besides, antibiotics are also known to improve performance, even when used in subtherapeutic doses. The perceived overuse of antibiotics in pig production, especially as growth promoters (AGP), have raised concerns from governments and public opinion, regarding the emergence of multidrug-resistant bacteria, adding a threat not only to animal but also human health. The challenges raised regarding AGPs and the need for their reduction in livestock led to the development of combined strategies such as the “One Health Approach”, where animal health, human health, and the environment are interlaced and must be considered in any animal production system.

In this scenario of intense changes, swine producers must evaluate strategies to adapt their production systems to accomplish the global pressure to reduce antibiotics and still have a profitable operation.

Many of these concerns focus on piglet nutrition, since the use of sub-therapeutic levels of antimicrobials as growth promotors is still a regular practice for preventing post-weaning diarrhea in many countries (Heo et al., 2013; Waititu et al., 2015). Taking that into consideration, this article serves as a practical guide to swine producers through AGP removal and its impacts on piglet performance and nutrition Three crucial points will be addressed:

  1. Why is AGP removal a global trend?
  2. What are the major consequences for piglet nutrition and performance?
  3. What alternatives do we have to guarantee optimum piglet performance in this scenario?

 

AGP removal: a global issue

Discussions on the future of the swine industry include understanding how and why AGP removal became such important topic worldwide. Historically, European countries have led discussions on eliminating AGP from livestock production. In Sweden, AGPs were banned from their farms as early as 1986. This move culminated into a total ban of AGPs in the European Union in 2006. Other countries followed same steps. In Korea, AGPs were removed from livestock operations in 2011. The USA is also putting efforts into limiting AGPs and the use of antibiotics in pig farms, as published in guidance revised by the Food and Drug Administration (FDA, 2019). In 2016, Brazil and China banned Colistin, and the Brazilian government also announced the removal of Tylosin, Tiamulin, and Lincomycin in 2020. Moreover, countries like India, Vietnam, Bangladesh, Buthan, and Indonesia have announced strategies for AGP restrictions (Cardinal et al., 2019; Davies and Walsh, 2018).

The major argument against AGPs and antibiotics in general is the already mentioned risk of the development of antimicrobial resistance, limiting the available tools to control and prevent diseases in human health. This point is substantiated by the fact that resistant pathogens are not static and exclusive to livestock, but can also spread to human beings (Barbosa and Bünzen, 2021). Moreover, concerns have been raised in regard to the fact that antibiotics in pig production are also used by humans – mainly third-generation antibiotics. The pressure on pig producers increased and it is today multifactorial: from official regulatory departments and stakeholders at different levels, who need to consider public concerns about antimicrobial resistance and its impact on livestock, human health, and the sustainability of farm operations (Stein, 2002).

It is evident that the process of reducing or banning antibiotics and AGPs in pig production is already a global issue and increasing as it takes on new dimensions. As Cardinal et al. (2019) suggest, that process is irreversible. Companies that want to access the global pork market and comply with increasingly stricter regulations on AGPs must re-invent their practices. This, however, is nothing new for the pig industry. For example, pig producers from the US and Brazil have adapted their operations in order to not use ractopamine to meet the requirements from the European and Asian markets. We can be sure, therefore, that the global pig industry will find a way to replace antibiotics.

With that in mind, the next step is to evaluate the consequences of AGP withdrawal from pig diets and how that affects the animals’ overall performance.

Consequences in piglet health and performance

Swine producers know very well that weaning pigs is challenging. Piglets are exposed to many biological stressors during that transitioning period, including introducing the piglets to new feed composition (going from milk to plant-based diets), abrupt separation from the sow, transportation and handling, exposure to new social interactions, and environmental adaptations, to name a few. Such stressors and physiological challenges can negatively impact health, growth performance, and feed intake due to immune systems dysfunctions (Campbell et al. 2013). Antibiotics have been a very powerful tool to mitigate this performance drop. The question then is, how difficult can this process become when AGPs are removed entirely?

Many farmers around the world still depend on AGPs to make the weaning period less stressful for piglets. One main benefit is that antibiotics will reduce the incidence of PWD, with subsequent improved growth performance (Long et al., 2018). The weaning process can create ideal conditions for the overgrowth of pathogens, as the piglets’ immune system is not completely developed and therefore not able to fight back. Those pathogens present in the gastrointestinal tract can lead to post-weaning diarrhea (PWD), among many other clinical diseases (Han et al., 2021). PWD is caused by Escherichia coli and is a global issue in the swine industry, as it compromises feed intake and growth performance throughout the pig’s life, also being a common cause for losses due to young pig death (Zimmerman, 2019).

Cardinal et al. (2021) also highlight that the hypothesis of a reduced intestinal inflammatory response is one explanation for the positive relationship between the use of AGPs and piglet weight gain.  Pluske et al. (2018) point out that overstimulation of the immune system can negatively affect pig growth rate and feed use efficiency. The process is physiologically expensive in terms of energy and also can cause excessive prostaglandin E2 (PGE2) production, leading to fever, anorexia, and reduction in pig performance. For instance, Mazutti et al. (2016) showed an increased weight gain of up to 1.74 kg per pig in animals that received colistin or tylosin in sub-therapeutic levels throughout the nursery. Helm et al. (2019) found that pigs medicated with chlortetracycline in sub-therapeutic levels increased average daily gain in 0.110 kg/day. Both attribute the higher weight to the decreased costs of immune activation determined by the action of AGPs on intestinal microflora.

On the other hand, although AGPs are an alternative for controlling bacterial diseases, they have also proved to be potentially deleterious to the beneficial microbiota and have long-lasting effects caused by microbial dysbiosis – abundance of potential pathogens, such as Escherichia and Clostridium; and a reduction of beneficial bacteria, such as Bacteroides, Bifidobacterium, and Lactobacillus (Guevarra et al., 2019; Correa-Fiz, 2019). Furthermore, AGPs reduced microbiota diversity, which was accompanied by general health worsening in the piglets (Correa-Fiz, 2019).

It is also important to highlight that the abrupt stress caused by suckling to weaning transition has consequences in diverse aspects of the function and structure of the intestine, which includes crypt hyperplasia, villous atrophy, intestinal inflammation, and lower activities of epithelial brush border enzyme (Jiang et al., 2019). Also, the movement of bacteria from the gut to the body can occur when the intestinal barrier function is deteriorated, which results in severe diarrhea and growth retardation. Therefore, nutrition and management strategies during that period are critical, and key gut nutrients must be used to support gut function and growth performance.

With all of that, it is more than never necessary to better understand the intestinal composition of young pigs and finding strategies to promote gut health are critical measures for preventing the overgrowth and colonization of opportunistic pathogens, and therefore being able to replace AGPs (Castillo et al., 2007).

Viable alternatives for protecting the piglets

The good news is that the swine industry already has effective alternatives that can replace AGP products and guarantee good animal performance.

Immunoglobulins from egg yolk (IgY) have proven to be a successful alternative to weaned piglet nutrition. Investigations have shown that egg antibodies improve the piglets’ gut microbiota, making it more stable (Han et al., 2021). Moreover, IgY optimizes piglet immunity and performance while reducing occurrences of diarrhea caused by E. coli, rotavirus, and Salmonella sp. (Li et al., 2016).

Phytomolecules (PM) are also potential alternatives for AGP removal, as they are bioactive compounds with antibacterial, antioxidant, and anti-inflammatory characteristics (Damjanović-Vratnica et al., 2011; Lee and Shibamoto, 2001). When used for piglet diet supplementation, phytomolecules optimize intestinal health and improve growth performance (Zhai et al., 2018).

Han et al. (2021) evaluated a combination of IgY (Globigen® Jump Start, EW Nutrition) and phytomolecules (Activo®, EW Nutrition) supplementation in weaned piglets’ diets. Results from that study (Table 1 and 2) showed that this strategy decreases the incidence of PWD and coliforms, increases feed intake, and improves the intestinal morphology of weaned pigs, making that combination a viable AGP replacement.

Table 1. Effect of dietary treatments on the growth performance of weaned pigs challenged with E. coli K88 (SOURCE: Han et al., 2021).

Table 2. Effect of dietary treatments on the post-weaning diarrhea incidence of weaned pigs challenged with E. coli K88 (%) (SOURCE: Han et al., 2021).

 

A trial conducted at the Institute of Animal Sciences of the Chinese Academy of Agricultural Sciences, China, supplemented weaning pigs challenged by E. coli K88 with a combination of PM (Activo®, EW Nutrition) and IgY (Globigen® Jump Start). The trial reported that this combination (AC/GJS) showed fewer diarrhea occurrences than in animals from the positive group (PC) during the first week after the challenge and similar diarrhea incidence to the AGP group during the 7th and 17th days after challenge (Figure 1).

Figure 1 – Incidence of diarrhea (%). NC: negative group, PC: positive group, AGP: supplementation with AGP, AC/GJS: combination of PM (Activo, EW Nutrition) and IgY (Globigen Jump Start).

 

The same trial also showed that the combination of these non-antibiotic additives was as efficient as the AGPs in improving pig performance under bacterial enteric challenges, showing positive effects on body weight, average daily gain (Figure 2), and feed conversion rate (Figure 3).

Figure 2 – Body weight (kg) and average daily gain (g). NC: negative group, PC: positive group, AGP: supplementation with AGP, AC/GJS: combination of PM (Activo, EW Nutrition) and IgY (Globigen Jump Start).

Figure 3 – Feed conversion rate. NC: negative group, PC: positive group, AGP: supplementation with AGP, AC/GJS: combination of PM (Activo, EW Nutrition) and IgY (Globigen Jump Start).

The multiple benefits of using IgY in piglet nutrition strategies are also highlighted by Rosa et al. (2015), Figure 4, and Prudius (2021).

Figure 4. Effect of treatments on the performance of newly weaned piglets. Means (±SEM) followed by letters a,b,c in the same group of columns differ (p < 0.05). NC (not challenged with ETEC, and diet with 40 ppm of colistin, 2300 ppm of zinc, and 150 ppm of copper). Treatments challenged with ETEC: GLOBIGEN® (0.2% of GLOBIGEN®); DPP (4% of dry porcine plasma); and PC (basal diet) (SOURCE: Rosa et al., 2015).

 

Conclusions

AGP removal and overall antibiotic reduction seems to be the only direction that the global swine industry must take for the future. From the front line, swine producers demand cost-effective AGP-free products that don’t compromise growth performance and animal health. Along with this demand, finding the best strategies for piglet nutrition in this scenario is critical in minimizing the adverse effects of weaning stress. With that in mind, alternatives such as egg immunoglobulins and phytomolecules are commercial options that are already showing great results and benefits, helping swine producers to go a step further into the future of swine nutrition.

 

References

Damjanović-Vratnica, Biljana, Tatjana Đakov, Danijela Šuković and Jovanka Damjanović, “Antimicrobial effect of essential oil isolated from Eucalyptus globulus Labill. from Montenegro,” Czech Journal of Food Sciences 29, no. 3 (2011): 277-284.

Pozzebon da Rosa, Daniele, Maite de Moraes Vieira, Alexandre Mello Kessler, Tiane Martin de Moura, Ana Paula Guedes Frazzon, Concepta Margaret McManus, Fábio Ritter Marx, Raquel Melchior and Andrea Machado Leal Ribeiro, “Efficacy of hyperimmunized hen egg yolks in the control of diarrhea in newly weaned piglets,” Food and Agricultural Immunology 26, no. 5 (2015): 622-634. https://doi.org/10.1080/09540105.2014.998639

Freitas Barbosa, Fellipe, Silvano Bünzen. Produção de suínos em épocas de restrição aos antimicrobianos–uma visão global. In: Suinocultura e Avicultura: do básico a zootecnia de precisão (2021): 14-33. https://dx.doi.org/10.37885/210203382

Correa-Fiz, Florencia, José Maurício Gonçalves dos Santos, Francesc Illas and Virginia Aragon, “Antimicrobial removal on piglets promotes health and higher bacterial diversity in the nasal microbiota,” Scientific reports 9, no. 1 (2019): 1-9. https://doi.org/10.1038/s41598-019-43022-y

Food and Drug Administration [FDA]. 2019. Animal drugs and animal food additives. Avaliable at: https://www.fda.gov/animalveterinary/development-approval-process/veterinary-feeddirective-vfd

Stein, Hans H , “Experience of feeding pigs without antibiotics: a European perspective,” Animal Biotechnology 13 no. 1(2002): 85-95. https://doi.org/10.1081/abio-120005772

Helm, Emma T, Shelby Curry, Julian M Trachsel, Martine Schroyen, Nicholas K Gabler, “Evaluating nursery pig responses to in-feed sub-therapeutic antibiotics”, PLoS One 14 no. 4 (2019). https://doi.org/10.1371/journal.pone.0216070.

Hengxiao Zhai, Hong Liu, Shikui Wang, Jinlong Wu and Anna-Maria Kluenter, “Potential of essential oils for poultry and pigs,” Animal Nutrition 4, no. 2 (2018): 179-186. https://doi.org/10.1016/j.aninu.2018.01.005

Pluske, J. R., Kim, J. C., Black, J. L. “Manipulating the immune system for pigs to optimise performance,” Animal Production Science 58, no 4, (2018): 666-680. https://doi.org/10.1071/an17598

Zimmerman, Jeffrey, Locke Karriker, Alejandro Ramirez, Kent Schwartz, Gregory Stevenson, Jianqiang Zhang (Eds.), “Diseases of Swine,” 11 (2019), Wiley Blackwell.

Campbell, Joy M, Joe D Crenshaw & Javier Polo, “The biological stress of early weaned piglets”, Journal of animal science and biotechnology 4, no. 1 (2013):1-4. https://doi.org/10.1186/2049-1891-4-19

Jung M. Heo, Opapeju, F. O., Pluske, J. R., Kim, J. C., Hampson, D. J., & Charles M. Nyachoti, “Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post‐weaning diarrhoea without using in‐feed antimicrobial compounds,” Journal of animal physiology and animal nutrition 97, no. 2 (2013): 207-237. https://doi.org/10.1111/j.1439-0396.2012.01284.x

Junjie Jiang, Daiwen Chen, Bing Yu, Jun He, Jie Yu, Xiangbing Mao, Zhiqing Huang, Yuheng Luo, Junqiu Luo, Ping Zheng, “Improvement of growth performance and parameters of intestinal function in liquid fed early weanling pigs,” Journal of animal science 97, no. 7 (2019): 2725-2738. https://doi.org/10.1093/jas/skz134

Cardinal, Kátia Maria, Ines Andretta, Marcos Kipper da Silva, Thais Bastos Stefanello, Bruna Schroeder and Andréa Machado Leal Ribeiro, “Estimation of productive losses caused by withdrawal of antibiotic growth promoter from pig diets – Meta-analysis,” Scientia Agricola 78, no.1 (2021): e20200266. http://doi.org/10.1590/1678-992X-2020-0266

Cardinal, Katia Maria, Marcos Kipper, Ines Andretta and Andréa Machado Leal Ribeiro, “Withdrawal of antibiotic growth promoters from broiler diets: Performance indexes and economic impact,” Poultry science 98, no. 12 (2019): 6659-6667. https://doi.org/10.3382/ps/pez536

Mazutti, Kelly, Leandro Batista Costa, Lígia Valéria Nascimento, Tobias Fernandes Filho, Breno Castello Branco Beirão, Pedro Celso Machado Júnior, Alex Maiorka, “Effect of colistin and tylosin used as feed additives on the performance, diarrhea incidence, and immune response of nursery pigs”, Semina: Ciências Agrárias 37, no. 4 (2016): 1947. https://doi.org/10.5433/1679-0359.2016v37n4p1947

Lee, Kwang-Geun and Takayuki Shibamoto, “Antioxidant activities of volatile components isolated from Eucalyptus species,” Journal of the Science of Food and Agriculture 81, no. 15 (2001): 1573-1579. https://doi.org/10.1002/jsfa.980

Long, S. F., Xu, Y. T., Pan, L., Wang, Q. Q., Wang, C. L., Wu, J. Y., … and Piao, X. S. Mixed organic acids as antibiotic substitutes improve performance, serum immunity, intestinal morphology and microbiota for weaned piglets,” Animal Feed Science and Technology 235, (2018): 23-32.

Davies, Madlen and Timothy R. Walsh, “A colistin crisis in India,” The Lancet. Infectious diseases 18, no. 3 (2018): 256-257. https://doi.org/10.1016/s1473-3099(18)30072-0

Castillo, Marisol, Susana M Martín-Orúe, Miquel Nofrarías, Edgar G Manzanilla and Josep Gasa, “Changes in caecal microbiota and mucosal morphology of weaned pigs”, Veterinary microbiology 124, no. 3-4 (2007): 239-247. https://doi.org/10.1016/j.vetmic.2007.04.026

Dyar, Oliver J, Jia Yin, Lilu Ding, Karin Wikander, Tianyang Zhang, Chengtao Sun, Yang Wang, Christina Greko, Qiang Sun and Cecilia Stålsby Lundborg, “Antibiotic use in people and pigs: a One Health survey of rural residents’ knowledge, attitudes and practices in Shandong province, China”, Journal of Antimicrobial Chemotherapy 73, no. 10 (2018): 2893-2899. https://doi.org/10.1093/jac/dky240

Prudius, T. Y., Gutsol, A. V., Gutsol, N. V., & Mysenko, O. O “Globigen Jump Start usage as a replacer for blood plasma in prestarter feed for piglets,” Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies, Series: Agricultural sciences 23, no. 94 (2021): 111-116. https://doi.org/10.32718/nvlvet-a9420

Guevarra, Robin B., Jun Hyung Lee, Sun Hee Lee, Min-Jae Seok, Doo Wan Kim, Bit Na Kang, Timothy J. Johnson, Richard E. Isaacson and Hyeun Bum, “Piglet gut microbial shifts early in life: causes and effects,” Journal of animal science and biotechnology 10, no. 1 (2019): 1-10. https://dx.doi.org/10.1186%2Fs40104-018-0308-3

Waititu, Samuel M., Jung M. Heo, Rob Patterson and Charles M. Nyachoti, “Dose-response effects of in-feed antibiotics on growth performance and nutrient utilization in weaned pigs fed diets supplemented with yeast-based nucleotides,” Animal Nutrition 1, no. 3 (2015): 166-169. https://doi.org/10.1016/j.aninu.2015.08.007

Xiaoyu Li, Ying Yao, Xitao Wang, Yuhong Zhen, Philip A Thacker, Lili Wang, Ming Shi, Junjun Zhao, Ying Zong, Ni Wang, Yongping Xu. “Chicken egg yolk antibodies (IgY) modulate the intestinal mucosal immune response in a mouse model of Salmonella typhimurium infection,” International immunopharmacology 36, (2016) 305-314. https://doi.org/10.1016/j.intimp.2016.04.036

Yunsheng Han, Tengfei Zhan, Chaohua Tang, Qingyu Zhao, Dieudonné M Dansou, Yanan Yu, Fellipe F Barbosa, Junmin Zhang. Effect of Replacing in-Feed Antibiotic Growth Promoters with a Combination of Egg Immunoglobulins and Phytomolecules on the Performance, Serum Immunity, and Intestinal Health of Weaned Pigs Challenged with Escherichia coli K88. Animals 11, no. 5 (2021): 1292. https://doi.o




Want better poultry performance? Focus on gut health

by Ruturaj Patil, Product Manager Phytogenic Liquids, EW Nutrition

Commercial poultry operations have undergone enormous changes in production practices over the last 50 years. Genetic selection for high production rates, along with upgraded management techniques and dietary measures, have led to increased performance standards in all poultry operations (Kogut et al., 2017). However, it is sensible to now look into whether poultry performance may soon reach a ceiling due to genetic and/or physiological limits. So, aiming at further performance optimization, poultry researchers and producers are now focusing on gut health.

LOWRES IMG
LOWRES IMG

Gut health management is key to sustainably improve poultry performance

The caveat, of course, is that, due to concerns about antimicrobial resistance, antimicrobial growth promoters (AGPs) no longer offer the easy answer to gut health issues they once were. To preserve antibiotics’ efficacy for cases where they are indispensable, gut health-oriented performance enhancement needs to come from other sources. This article reviews the principles of gut health management in poultry and shows how Activo liquid, a phytomolecules-based in-water solution, strengthens poultry performance by targeting gut health.

Gut health: the cradle of poultry performance

Gastrointestinal health in poultry birds encompasses three dimensions: microflora balance, gut structural integrity, and immune system status. The gut plays a vital and diverse role as it hosts most microorganisms in the body, contains more than twenty different hormones, digests and absorbs the nutrients, and accounts for 20% of body energy expenditure (Choct, 2021). When gut health is compromised, digestion and nutrient absorption are affected, with likely detrimental effects on feed conversion, followed by economic loss and greater disease susceptibility.  Disease resistance and nutrient utilization largely depend on maintaining a beneficial gut antioxidant status, improving gut integrity, and modulating the gut microbiota (Oviedo-Rondón, 2019).

In birds, the gut is separated into five distinct regions (Figure 1): crop, proventriculus, gizzard, small intestine (duodenum, jejunum, and ileum), and large intestine (ceca, cloaca, and vent). Each of these regions has a specific role in the secretion of digestive juices and enzymes, the grinding of feed particles and then the digestion and absorption of nutrients (Bailey 2019).

Schematic overview of poultry gastrointestinal tractFigure 1: Schematic overview of poultry gastrointestinal tract

Factors affecting gut health

Gut health is influenced by the balance between the physiological health status of host, the gut microbiota, and a range of specific factors, all of which producers need to consider. From a management perspective, key factors encompass deprived gut health, biosecurity, and production stress, which is elevated during certain critical stages (see table 1). Environmental factors include humidity, temperature, and ventilation. Dietary factors, such as feed and water quality, feed composition, and mycotoxin contamination, also impact the development and ongoing state of poultry birds’ intestinal microbiota.

Critical stages for gut health issues in poultry birdsTable 1: Critical stages for gut health issues in poultry birds

The future is here: antibiotic reduction through improved gut health

There is a strong trend towards antibiotic-free (ABF) poultry production, fueled by AGP bans in certain regions (such as the European Union) and increasing consumer interest in avoiding products containing traces of AGPs. ABF systems can be profitable as long as the prices for the final ABF products can cover the investment costs necessary to produce these products. Larger-scale, sustainable ABF production will depend on developing a more profound understanding of intestinal health alongside the development of practical applications that foster gut health throughout each step of the production system.

Feed additive solutions to support birds during challenging situations

Feed additive manufacturers are looking into accessible alternatives to mitigate the need for antibiotics in ABF systems, requiring enormous research and development efforts. At EW Nutrition, our approach is to offer a holistic antibiotic reduction program for gut health management in poultry. The program comprises feed- and water-based solutions to support gut health during high-challenge periods. Activo liquid, an in-water solution containing standardized amounts of selected phytomolecules, is a key component of our program. Based on its three-fold mode of action, Activo liquid provides gut health support that improves livability and feed efficiency:

  • Antimicrobial activity hinders the growth of potential pathogens
  • Better gut integrity and positive microbiota optimize feed efficiency and gut health
  • Antioxidant activity at the gut level prevent free radical formation and oxidative stress

As a water-based solution, Activo liquid provides a quick and flexible option for gut health control on poultry farms. The benefits of Activo liquid supplementation have been demonstrated through several scientific and field studies globally.

Activo liquid reduces mortality and improves feed conversion in broilers

Numerous field studies for antibiotic-free broilers across different countries and breeds show: on average, the inclusion of Activo liquid reduces mortality by 0.6% and improves FCR by 5%, compared to non-supplemented control groups (Figure 2).

Changes in livability and feed conversion rate in Activo liquid-supplemented broilersFigure 2: Changes in livability and feed conversion rate in Activo liquid-supplemented broilers

Activo Liquid supports broiler breeders from start of lay to pre-peak production

Broiler breeders are prone to gut-related issues from the start of lay to pre-peak production (age 24 to 32 weeks). This period is characterized by sudden changes in feed consumption and high production stress. Field studies from Thailand show that Activo liquid supplementation in this phase leads to improved livability and higher laying rates.

A of 34,000 female broiler breeders during the first 9 weeks of production found that for the group receiving Activo Liquid  (200 ml / 1000 L, 5 days per week, 6 hours per day):

  • The average laying rate/HH increased by 7.2 % during the trial period,
  • Nearly 3  more  hatching  eggs  per  hen  housed  and  about  5  more  hatching  eggs  than  the  genetic standard were produced, and
  • Mortality decreased by 0.2 % points compared to the control.

Another study, again evaluating the first 9 weeks of production using 20,000 birds, also found that broiler breeders supplemented with  Activo  Liquid show reduced mortality, a higher laying rate, and more hatching eggs per hen housed (Figure 3).

Performance results from Cobb broiler breeders, Activo liquid supplementation vs. controlFigure 3: Performance results from Cobb broiler breeders, Activo liquid supplementation vs. control

Activo program improves layer productivity

Commercial layers often becomes challenged due to stress originating from management issues, gut pathogens, and an improper assimilation of nutrients. The negative impact on gut health can result in poor uniformity, low livability, and impaired body weight gain. The Activo program (a combination of Activo powder and liquid) has been found to improve layer performance, likely because its phytogenic components foster better intestinal integrity and microbiome diversity.

A study of 8 replicates with 36 Hy-line brown laying hens was conducted in China, for instance, testing the inclusion of both Activo (100 g / MT of feed) and Activo Liquid (250 ml / 1000 L for 4 days, every 2 weeks, from week 15 to week 25). It found that the Activo program  can effectively support the animals in coping with NSP-rich diets (Figure 4). Supplemented layers showed 3.36% higher egg production, representing more than 3.5 eggs and more than 150 grams of additional egg mass per hen housed during the period.  Better  gut  health  in  the  Activo  Program  gut  was evidenced  by  a  better  hen  body  weight ,  as  well  as  higher  yolk  color, lower  FCR, and improved  intestinal morphology parameters.

Performance results from Hy-line layers, Activo program vs. control, body weight and FCR

Performance results from Hy-line layers, Activo program vs. control, eggsFigure 4: Performance results from Hy-line layers, Activo program vs. control

Conclusion: future improvements in poultry performance will come from the gut

As the trend towards ABF poultry production gains momentum, a concerted focus on supporting birds’ gut health is key to achieving optimal performance. Multiple field studies of Activo liquid application demonstrate that, due to their antimicrobial and antioxidant properties, the phytomolecules present in Activo liquid effectively support birds’ intestinal health during challenging periods.

In combination with good dietary, hygiene and management practices, phytomolecules offer a potent tool for reducing the use of antibiotics. The inclusion of Activo liquid in their birds’ diets allows poultry producers to achieve better gut health and, thus, stronger performance results in a sustainable way.

 


References

Bailey, Richard A. “Gut Health in Poultry: the World within – Update.” The Poultry Site, July 6, 2021. https://www.thepoultrysite.com/articles/gut-health-in-poultry-the-world-within-1.

Choct, Mingan. “The Importance of Managing Gut Health in Poultry.” Poultry Hub Australia, November 26, 2014. https://www.poultryhub.org/importance-managing-gut-health-poultry.

Kogut, Michael H., Xiaonan Yin, Jianmin Yuan, and Leon Bloom. “Gut Health in Poultry.” CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources 12, no. 031 (October 1, 2017): 1–7. https://doi.org/10.1079/pavsnnr201712031.

Oviedo-Rondón, Edgar O. “Holistic View of Intestinal Health in Poultry.” Animal Feed Science and Technology 250 (2019): 1–8. https://doi.org/10.1016/j.anifeedsci.2019.01.009.